Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAPATINIB vs LAPATINIB DITOSYLATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LAPATINIB vs LAPATINIB DITOSYLATE: Safety Overview

Metric LAPATINIB LAPATINIB DITOSYLATE
Total FAERS Reports 1,983 3,948
Deaths Reported 267 921
Death Rate 13.5% 23.3%
Hospitalizations 498 752
Average Patient Age 54.1 yrs 57.3 yrs
% Female Patients 96.6% 95.0%
FDA Approval Date N/A Aug 16, 2024
Manufacturer N/A AvKARE
Route N/A ORAL
Marketing Status N/A Prescription